Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Starsha Kolodziej"'
Autor:
Analise Z. Reeves, Starsha Kolodziej, Jenny Shu, Chun-Cheih Chao, Jillian Means, Catherine Monahan, David Lubkowicz, Michael James, Mylene Perreault, Vincent Isabella, David Hava
Publikováno v:
Gastroenterology. 162:S-455
Autor:
Chun-Cheih Chao, Jenny Shu, Starsha Kolodziej, Catherine Monahan, Michael James, Douglas J. Kenny, Mylene Perreault, Vincent Isabella, David Hava
Publikováno v:
Gastroenterology. 162:S-406
Autor:
Carey W. Gallant, Christopher Plescia, Paul F. Miller, Michael J. James, Kip A. West, Rudy Christmas, Daniel S. Leventhal, Jian-Rong Gao, Ning Li, Adam B. Fisher, Starsha Kolodziej, Munira Momin, Christopher Bergeron, Anna Sokolovska, Andres Abin-Fuentes, Jose M. Lora
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Synthetic biology is a powerful tool to create therapeutics which can be rationally designed to enable unique and combinatorial functionalities. Here we utilize non-pathogenic E coli Nissle as a versatile platform for the development of a living biot
Autor:
Christopher Bergeron, Anna Sokolovska, Starsha Kolodziej, Jillian Means, Caroline B. Kurtz, David Hava, Mylene Perreault, Ning Li
Publikováno v:
Gastroenterology. 160:S-142
Autor:
Mary Castillo, Adam B. Fisher, Paul S. Miller, Starsha Kolodziej, Ning Li, Jose M. Lora, Daniel S. Leventhal, Carey W. Gallant, Anna Sokolovska, Chris Plescia, Kip A. West
Publikováno v:
Cancer Research. 78:LB-131
Background: While both T-cell priming and blockade of immune suppression play critical roles in the generation of an efficacious antitumor immune response, most therapies fail to support both processes as a single agent. At Synlogic we are using synt
Autor:
Mary Castillo, Vincent M. Isabella, Jose M. Lora, Ning Li, Paul S. Miller, Chris Plescia, Kip A. West, Anna Sokolovska, Dan Leventhal, Starsha Kolodziej, Adam B. Fisher
Publikováno v:
Cancer Research. 78:2920-2920
Background: The immunosuppressive milieu found within the tumor microenvironment (TME) has long been understood to be a key driver of tumor initiation and progression. More recently it has been appreciated that metabolites derived from biosynthetic p